source
- Sarepta appoints Michael Severino as CEO to steer company beyond a turbulent yearSarepta Therapeutics announced that Michael Severino will become its chief executive officer, taking over from longtime leader Doug Ingram. Severino is slated to start on Tuesday and joins the com…
- From confidence to capital: Positioning biotech for the next growth cycleHow can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.